Walking Away from Type 2 diabetes: a cluster randomized controlled trial.
Study Goal
The researchers aimed to determine if the "Walking Away from Type 2 Diabetes" intervention effectively increased and sustained walking activity in high-risk individuals when delivered in primary care.
Results Summary
The intervention resulted in a modest increase of 411 steps/day at 12 months compared to control, but these differences were not sustained at 36 months. No significant improvements in cardiometabolic health markers were observed.
Population
Individuals at high risk of Type 2 diabetes mellitus (36% female) identified through a validated risk score.
Effective Dosage
A pragmatic 3-hour group-based structured education program with pedometer use and annual refresher sessions.
Duration
12 months (primary outcome), with follow-up at 24 and 36 months.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Walking Away from Type 2 Diabetes (a pragmatic 3-h group-based structured education programme incorporating pedometer use with annual follow-on refresher sessions) | increase | ambulatory activity (steps/day) | individuals with a high risk of Type 2 diabetes mellitus | 411 steps/day | increases in ambulatory activity | #1 |
Walking Away from Type 2 Diabetes (a pragmatic 3-h group-based structured education programme incorporating pedometer use with annual follow-on refresher sessions) | increase | vigorous-intensity physical activity | individuals with a high risk of Type 2 diabetes mellitus | 218 metabolic equivalent min/week | increases in self-reported vigorous-intensity physical activity | #2 |
Walking Away from Type 2 Diabetes (a pragmatic 3-h group-based structured education programme incorporating pedometer use with annual follow-on refresher sessions) | no change | ambulatory activity | individuals with a high risk of Type 2 diabetes mellitus | not sustained at 36 months | differences between groups were not sustained | #3 |
Walking Away from Type 2 Diabetes (a pragmatic 3-h group-based structured education programme incorporating pedometer use with annual follow-on refresher sessions) | no change | markers of cardiometabolic health | individuals with a high risk of Type 2 diabetes mellitus | - | No differences between groups were observed | #4 |
AIMS: This study aimed to investigate whether an established behavioural intervention, Walking Away from Type 2 Diabetes, is effective at promoting and sustaining increased walking activity when delivered within primary care. METHODS: Cluster randomized controlled trial involving 10 general practices recruited from Leicestershire, UK, in 2009-2010. Eight hundred and eight (36% female) individuals with a high risk of Type 2 diabetes mellitus, identified through a validated risk score, were included. Participants in five practices were randomized to Walking Away from Type 2 Diabetes, a pragmatic 3-h group-based structured education programme incorporating pedometer use with annual follow-on refresher sessions. The primary outcome was accelerometer assessed ambulatory activity (steps/day) at 12 months. Longer term maintenance was assessed at 24 and 36 months. Results were analysed using generalized estimating equation models, accounting for clustering. RESULTS: Complete accelerometer data for the primary outcome were available for 571 (71%) participants. Increases in ambulatory activity of 411 steps/day [95% confidence interval (CI): 117, 704] and self-reported vigorous-intensity physical activity of 218 metabolic equivalent min/week (95% CI: 6, 425) at 12 months were observed in the intervention group compared with control; differences between groups were not sustained at 36 months. No differences between groups were observed for markers of cardiometabolic health. Replacing missing data with multiple imputation did not affect the results. CONCLUSIONS: A pragmatic low-resource group-based structured education programme with pedometer use resulted in modest increases in ambulatory activity compared with control conditions after 12 months when implemented within a primary care setting to those at high risk of Type 2 diabetes mellitus; however, the results were not maintained over 36 months.